Company Overview - Hualan Pharmaceutical Materials Co., Ltd. is located in Jiangyin City, Jiangsu Province, and was established on June 4, 1992. The company went public on November 1, 2021. Its main business involves the research, production, and sales of packaging materials for injectable drugs [1]. Financial Performance - As of November 24, Hualan shares increased by 5.05%, trading at 47.66 CNY per share, with a transaction volume of 111 million CNY and a turnover rate of 1.53%. The total market capitalization is 7.826 billion CNY [1]. - The company's main revenue sources are: film-coated rubber stoppers (49.07%), conventional rubber stoppers (48.50%), and others (2.43%) [1]. Fund Holdings - Hualan shares are a significant holding in the Galaxy Fund, specifically in the Galaxy Kangle Stock A fund (519673), which reduced its holdings by 130,300 shares in the third quarter, now holding 225,500 shares, accounting for 4.88% of the fund's net value [2]. - The Galaxy Kangle Stock A fund was established on November 18, 2014, with a current size of 156 million CNY. Year-to-date returns are 18.83%, ranking 2266 out of 4209 in its category, while the one-year return is 13.28%, ranking 2596 out of 3982 [2]. Fund Management - The fund manager of Galaxy Kangle Stock A is Fang Wei, who has been in the position for 4 years and 200 days. The total asset size of the fund is 703 million CNY, with the best return during his tenure being -12.65% and the worst being -25.26% [3].
华兰股份股价涨5.05%，银河基金旗下1只基金重仓，持有22.55万股浮盈赚取51.65万元